MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 212 filers reported holding MEDICINES CO in Q4 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $982,000 | +17.3% | 19,635 | -14.4% | 0.20% | +12.5% |
Q2 2019 | $837,000 | +37.4% | 22,945 | -27.9% | 0.18% | +69.2% |
Q4 2018 | $609,000 | -4.5% | 31,840 | +49.2% | 0.10% | +57.6% |
Q3 2018 | $638,000 | -12.6% | 21,335 | +7.2% | 0.07% | -89.8% |
Q2 2018 | $730,000 | -33.4% | 19,897 | -40.2% | 0.64% | -32.2% |
Q1 2018 | $1,096,000 | +13.8% | 33,271 | -5.5% | 0.95% | -21.3% |
Q4 2017 | $963,000 | -3.9% | 35,217 | +30.1% | 1.21% | +794.8% |
Q3 2017 | $1,002,000 | -2.6% | 27,060 | 0.0% | 0.14% | -12.3% |
Q2 2017 | $1,029,000 | -25.5% | 27,060 | -4.2% | 0.15% | -37.4% |
Q1 2017 | $1,381,000 | +59.3% | 28,251 | +10.6% | 0.25% | -5.0% |
Q4 2016 | $867,000 | +34.6% | 25,534 | +49.6% | 0.26% | -16.7% |
Q3 2016 | $644,000 | +28.3% | 17,070 | +14.4% | 0.31% | -16.6% |
Q2 2016 | $502,000 | +3.1% | 14,919 | -2.7% | 0.37% | -44.4% |
Q1 2016 | $487,000 | -14.9% | 15,331 | 0.0% | 0.67% | -57.3% |
Q4 2015 | $572,000 | – | 15,331 | – | 1.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |